Inhalation Sciences Sweden Gelecekteki Büyüme
Future kriter kontrolleri 2/6
Inhalation Sciences Sweden is forecast to grow revenue at 59.5% per annum.
Anahtar bilgiler
n/a
Kazanç büyüme oranı
n/a
EPS büyüme oranı
Life Sciences kazanç büyümesi | 50.8% |
Gelir büyüme oranı | 59.5% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 29 Feb 2024 |
Gelecekteki son büyüme güncellemeleri
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2025 | 66 | N/A | N/A | N/A | 1 |
12/31/2024 | 38 | N/A | N/A | 5 | 1 |
12/31/2023 | 18 | -5 | -4 | -4 | N/A |
9/30/2023 | 17 | -5 | -4 | -4 | N/A |
6/30/2023 | 15 | -7 | -3 | -3 | N/A |
3/31/2023 | 13 | -11 | -6 | -6 | N/A |
12/31/2022 | 12 | -12 | -12 | -12 | N/A |
9/30/2022 | 12 | -14 | -14 | -14 | N/A |
6/30/2022 | 12 | -15 | -17 | -17 | N/A |
3/31/2022 | 9 | -17 | -19 | -19 | N/A |
12/31/2021 | 9 | -17 | -19 | -19 | N/A |
9/30/2021 | 7 | -18 | -18 | -18 | N/A |
6/30/2021 | 6 | -16 | -13 | -13 | N/A |
3/31/2021 | 7 | 6 | -9 | -9 | N/A |
12/31/2020 | 10 | 10 | -6 | -5 | N/A |
9/30/2020 | 12 | 12 | -7 | -6 | N/A |
6/30/2020 | 14 | 12 | -11 | -9 | N/A |
3/31/2020 | 14 | -1 | -12 | -9 | N/A |
12/31/2019 | 9 | -4 | -12 | -9 | N/A |
9/30/2019 | 9 | -3 | -12 | -9 | N/A |
6/30/2019 | 8 | -3 | -13 | -11 | N/A |
3/31/2019 | 6 | -11 | -11 | -10 | N/A |
12/31/2018 | 5 | -12 | -11 | -10 | N/A |
9/30/2018 | 5 | -12 | -7 | -7 | N/A |
6/30/2018 | 6 | -10 | -6 | -6 | N/A |
3/31/2018 | 7 | -9 | -5 | -5 | N/A |
12/31/2017 | 8 | -6 | -7 | -7 | N/A |
9/30/2017 | 6 | -7 | N/A | -6 | N/A |
6/30/2017 | 6 | -7 | N/A | -6 | N/A |
3/31/2017 | 8 | -6 | N/A | -6 | N/A |
12/31/2016 | 10 | -5 | N/A | -6 | N/A |
12/31/2015 | 10 | -3 | N/A | -3 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: Insufficient data to determine if ISAB's forecast earnings growth is above the savings rate (0.9%).
Kazançlar ve Piyasa: Insufficient data to determine if ISAB's earnings are forecast to grow faster than the Swedish market
Yüksek Büyüme Kazançları: Insufficient data to determine if ISAB's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: ISAB's revenue (59.5% per year) is forecast to grow faster than the Swedish market (1.6% per year).
Yüksek Büyüme Geliri: ISAB's revenue (59.5% per year) is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if ISAB's Return on Equity is forecast to be high in 3 years time